NASDAQ:ALBT - Nasdaq - US05344R3021 - Common Stock - Currency: USD
5.42
+0.52 (+10.61%)
The current stock price of ALBT is 5.42 USD. In the past month the price increased by 56.65%. In the past year, price decreased by -8.27%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LB | LANDBRIDGE CO LLC-A | N/A | 4.99B | ||
VTMX | CORP INMOBILIARIA VESTA-ADR | N/A | 2.13B | ||
KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.22B | ||
IRS | IRSA -SP ADR | N/A | 1.01B | ||
MRNO | MURANO GLOBAL INVESTMENTS PL | N/A | 913.30M | ||
FRPH | FRP HOLDINGS INC | 55.91 | 585.17M | ||
LPA | LOGISTIC PROPERTIES OF THE A | N/A | 310.69M | ||
SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 300.72M | ||
TCI | TRANSCONTINENTAL REALTY INV | 75.27 | 240.62M | ||
OZ | BELPOINTE PREP LLC | N/A | 239.63M | ||
NEN | NEW ENGLAND REALTY ASSOC-LP | 0.7 | 229.60M | ||
ARL | AMERICAN REALTY INVESTORS IN | N/A | 223.84M |
Avalon Globocare Corp is a US-based company operating in Real Estate Management & Development industry. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The firm offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. The company operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. The company is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
AVALON GLOBOCARE CORP
4400 Route 9, Suite 3100
Freehold NEW JERSEY US
Employees: 5
Company Website: http://www.avalon-globocare.com/
Investor Relations: http://www.avalon-globocare.com/investors
Phone: 17327804400
The current stock price of ALBT is 5.42 USD. The price increased by 10.61% in the last trading session.
The exchange symbol of AVALON GLOBOCARE CORP is ALBT and it is listed on the Nasdaq exchange.
ALBT stock is listed on the Nasdaq exchange.
AVALON GLOBOCARE CORP (ALBT) has a market capitalization of 5.91M USD. This makes ALBT a Nano Cap stock.
AVALON GLOBOCARE CORP (ALBT) currently has 5 employees.
AVALON GLOBOCARE CORP (ALBT) has a support level at 3.52. Check the full technical report for a detailed analysis of ALBT support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALBT does not pay a dividend.
AVALON GLOBOCARE CORP (ALBT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-19.56).
The outstanding short interest for AVALON GLOBOCARE CORP (ALBT) is 1.06% of its float. Check the ownership tab for more information on the ALBT short interest.
ChartMill assigns a technical rating of 8 / 10 to ALBT. When comparing the yearly performance of all stocks, ALBT is one of the better performing stocks in the market, outperforming 94.87% of all stocks.
Over the last trailing twelve months ALBT reported a non-GAAP Earnings per Share(EPS) of -19.56. The EPS decreased by -2025.81% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -75.36% | ||
ROE | -272.78% | ||
Debt/Equity | 0.73 |